Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
November 19, 2012
11/21/2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
November 8, 2012
11/14/2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
October 25, 2012
10/30/2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
October 21, 2012
10/24/2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration...
October 11, 2012
10/16/2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license...
October 7, 2012
10/10/2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...
September 16, 2012
9/19/2012
PharmaTelevision Spotlights Aptalis' Year in Review FDA approvals, revenue gain, and organic business growth are just a few of the...
September 16, 2012
Ei Gains Exclusive World-Wide License
Metro Charlotte-based Ei has signed agreements with European-based professors and technologists for the exclusive worldwide license of a novel class...
September 10, 2012
9/12/2012
Cobra Biologics & Algeta Sign Monoclonal Antibody Agreement Cobra Biologics Ltd and Algeta ASA recently announced a new contract manufacturing...
September 10, 2012
InSite Vision Introduces DuraSite 2
InSite Vision Incorporated recently introduced DuraSite 2, its next-generation enhanced drug delivery system that provides a broad platform for developing...
